Corteva (NYSE:CTVA) Reaches New 12-Month High – What’s Next?

Corteva, Inc. (NYSE:CTVA) reached a new 52-week high during mid-day trading on Friday . The company traded as high as $87.89 and last traded at $87.8060, with a volume of 269353 shares changing hands. The stock had previously closed at $86.65.

Analyst Ratings Changes

A number of brokerages have recently commented on CTVA. The Goldman Sachs Group boosted their price objective on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, April 14th. Morgan Stanley raised their target price on shares of Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 28th. Argus lifted their price target on shares of Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a research note on Tuesday, March 31st. Royal Bank Of Canada boosted their price target on shares of Corteva from $95.00 to $97.00 and gave the stock an “outperform” rating in a research report on Thursday, May 7th. Finally, Wells Fargo & Company increased their price objective on shares of Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 21st. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $88.95.

Corteva Trading Up 0.9%

The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The firm has a fifty day moving average price of $80.86 and a 200 day moving average price of $78.19. The company has a market cap of $58.47 billion, a price-to-earnings ratio of 51.43, a P/E/G ratio of 2.67 and a beta of 0.56.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The business had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities analysts predict that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were paid a dividend of $0.18 per share. The ex-dividend date was Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.8%. Corteva’s payout ratio is currently 42.35%.

Institutional Investors Weigh In On Corteva

Hedge funds have recently bought and sold shares of the company. Drummond Knight Asset Management Pty Ltd bought a new stake in shares of Corteva in the fourth quarter valued at approximately $25,713,000. Avior Wealth Management LLC increased its stake in Corteva by 464.7% during the 4th quarter. Avior Wealth Management LLC now owns 32,901 shares of the company’s stock worth $2,205,000 after acquiring an additional 27,075 shares during the period. Arbejdsmarkedets Tillaegspension acquired a new position in Corteva in the 4th quarter valued at $23,679,000. Mirae Asset Global Investments Co. Ltd. raised its holdings in Corteva by 23.5% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,075 shares of the company’s stock valued at $7,378,000 after acquiring an additional 20,957 shares in the last quarter. Finally, Leonteq Securities AG bought a new stake in shares of Corteva during the 4th quarter valued at $2,350,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.